(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of XPA mRNA] CTD PMID:31150632 (+)-taxifolin increases expression ISO RGD:1318735 6480464 taxifolin results in increased expression of XPA mRNA CTD PMID:17541156 (-)-quinic acid multiple interactions ISO RGD:1318735 6480464 [Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of XPA mRNA CTD PMID:21751221 1,1'-azobis(N,N-dimethylformamide) decreases activity ISO RGD:1318736 6480464 Diamide results in decreased activity of XPA protein CTD PMID:15265038 1,2-dichloroethane decreases expression ISO RGD:1318736 6480464 ethylene dichloride results in decreased expression of XPA mRNA CTD PMID:28960355 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of XPA mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of XPA mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1318735 6480464 Tetrachlorodibenzodioxin affects the expression of XPA mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1318736 6480464 Tetrachlorodibenzodioxin affects the expression of XPA mRNA CTD PMID:21570461 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of XPA mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1318735 6480464 Lactic Acid results in decreased expression of XPA mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1318735 6480464 3 more ... CTD PMID:19553035 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1318735 6480464 [3 more ... CTD PMID:19553035 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1318735 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of XPA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of XPA mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane affects expression ISO RGD:1318736 6480464 4, 4'-diaminodiphenylmethane affects the expression of XPA mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1318735 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of XPA mRNA CTD PMID:28628672 7,12-dimethyltetraphene affects response to substance ISO RGD:1318736 6480464 XPA protein affects the susceptibility to 9 more ... CTD PMID:10755388 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of XPA mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:1318735 6480464 Acrylamide results in increased expression of XPA mRNA CTD PMID:32763439 aflatoxin B1 decreases response to substance ISO RGD:1318736 6480464 XPA protein results in decreased susceptibility to Aflatoxin B1 CTD PMID:23153559 all-trans-retinoic acid decreases expression ISO RGD:1318735 6480464 Tretinoin results in decreased expression of XPA mRNA CTD PMID:33167477 antimony trichloride multiple interactions ISO RGD:1318735 6480464 antimony trichloride inhibits the reaction [XPA protein binds to Zinc] CTD PMID:20509621 antimony trichloride affects binding ISO RGD:1318735 6480464 antimony trichloride binds to XPA protein CTD PMID:20509621 arsane affects response to substance ISO RGD:1318735 6480464 XPA polymorphism affects the susceptibility to Arsenic CTD PMID:17687452 arsane multiple interactions ISO RGD:1318735 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPA mRNA more ... CTD PMID:32031413 arsenic atom affects response to substance ISO RGD:1318735 6480464 XPA polymorphism affects the susceptibility to Arsenic CTD PMID:17687452 arsenic atom multiple interactions ISO RGD:1318735 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPA mRNA more ... CTD PMID:32031413 arsenite(3-) multiple interactions ISO RGD:1318735 6480464 XPA protein affects the reaction [arsenite results in decreased expression of AKT1 mRNA] more ... CTD PMID:18585952 arsenous acid decreases expression ISO RGD:1318736 6480464 Arsenic Trioxide results in decreased expression of XPA mRNA CTD PMID:15073043 atrazine increases expression ISO RGD:1318735 6480464 Atrazine results in increased expression of XPA mRNA CTD PMID:22378314 benzene decreases expression ISO RGD:1318735 6480464 Benzene results in decreased expression of XPA mRNA CTD PMID:18724895 benzo[a]pyrene multiple interactions ISO RGD:1318735 6480464 [3 more ... CTD PMID:19553035 , PMID:30020114 benzo[a]pyrene decreases expression ISO RGD:1318736 6480464 Benzo(a)pyrene results in decreased expression of XPA mRNA CTD PMID:30020114 benzo[a]pyrene decreases expression ISO RGD:1318735 6480464 Benzo(a)pyrene results in decreased expression of XPA mRNA CTD PMID:26238291 , PMID:30020114 benzo[a]pyrene multiple interactions ISO RGD:1318736 6480464 [lipopolysaccharide more ... CTD PMID:23052197 , PMID:28987381 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of XPA protein CTD PMID:21467743 benzo[a]pyrene increases expression ISO RGD:1318735 6480464 Benzo(a)pyrene results in increased expression of XPA protein CTD PMID:19553035 , PMID:19748547 benzo[a]pyrene affects localization ISO RGD:1318735 6480464 Benzo(a)pyrene affects the localization of XPA protein CTD PMID:19748547 benzo[a]pyrene increases response to substance ISO RGD:1318736 6480464 XPA gene mutant form results in increased susceptibility to Benzo(a)pyrene CTD PMID:21715664 benzo[a]pyrene affects response to substance ISO RGD:1318735 6480464 XPA 5' UTR polymorphism affects the susceptibility to Benzo(a)pyrene CTD PMID:15471894 bis(2-chloroethyl) sulfide decreases response to substance ISO RGD:1318735 6480464 XPA results in decreased susceptibility to Mustard Gas CTD PMID:22119920 bis(2-chloroethyl) sulfide increases expression ISO RGD:1318735 6480464 Mustard Gas results in increased expression of XPA mRNA CTD PMID:33491125 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of XPA mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A decreases expression ISO RGD:1318736 6480464 bisphenol A results in decreased expression of XPA mRNA CTD PMID:33221593 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in decreased expression of XPA mRNA CTD PMID:31129395 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of XPA mRNA CTD PMID:30816183 bisphenol A multiple interactions ISO RGD:1318735 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of XPA mRNA CTD PMID:28628672 cadmium atom affects binding ISO RGD:1318735 6480464 Cadmium binds to XPA protein CTD PMID:10783332 , PMID:17512921 cadmium dichloride decreases activity ISO RGD:1318735 6480464 Cadmium Chloride results in decreased activity of XPA protein CTD PMID:17512921 cadmium dichloride decreases expression ISO RGD:1318736 6480464 Cadmium Chloride results in decreased expression of XPA mRNA CTD PMID:11958953 cadmium dichloride multiple interactions ISO RGD:1318736 6480464 MT1 affects the reaction [Cadmium Chloride results in decreased expression of XPA mRNA], MT2 affects the reaction [Cadmium Chloride results in decreased expression of XPA mRNA] CTD PMID:11958953 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of XPA promoter CTD PMID:22457795 cadmium dichloride multiple interactions ISO RGD:1318735 6480464 Zinc inhibits the reaction [Cadmium Chloride results in decreased activity of XPA protein] CTD PMID:17512921 carbamazepine affects expression ISO RGD:1318735 6480464 Carbamazepine affects the expression of XPA mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1318736 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1318736 6480464 Nanotubes, Carbon analog results in increased expression of XPA mRNA CTD PMID:25620056 chloroethene affects response to substance ISO RGD:1318735 6480464 XPA gene polymorphism affects the susceptibility to Vinyl Chloride CTD PMID:21216194 cisplatin decreases response to substance ISO RGD:1318735 6480464 XPA mRNA results in decreased susceptibility to Cisplatin, XPA protein results in decreased susceptibility to Cisplatin CTD PMID:15882455 , PMID:21324906 cisplatin increases expression ISO RGD:1318735 6480464 Cisplatin results in increased expression of XPA protein CTD PMID:21696631 cisplatin multiple interactions ISO RGD:1318735 6480464 XPA mutant form inhibits the reaction [RRM2 mutant form promotes the reaction [TP53 mutant form promotes the reaction [Cisplatin results in increased phosphorylation of H2AX protein]]] CTD PMID:21875941 copper atom multiple interactions ISO RGD:1318735 6480464 [NSC 689534 binds to Copper] which results in decreased expression of XPA mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1318735 6480464 [NSC 689534 binds to Copper] which results in decreased expression of XPA mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1318735 6480464 Copper Sulfate results in decreased expression of XPA mRNA CTD PMID:19549813 cyclosporin A affects response to substance ISO RGD:1318736 6480464 XPA protein affects the susceptibility to Cyclosporine CTD PMID:23153559 cyclosporin A decreases expression ISO RGD:1318735 6480464 Cyclosporine results in decreased expression of XPA mRNA CTD PMID:25562108 dexamethasone multiple interactions ISO RGD:1318735 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of XPA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of XPA mRNA CTD PMID:28628672 diarsenic trioxide decreases expression ISO RGD:1318736 6480464 Arsenic Trioxide results in decreased expression of XPA mRNA CTD PMID:15073043 doxorubicin increases expression ISO RGD:1318736 6480464 Doxorubicin results in increased expression of XPA mRNA CTD PMID:22712078 ebselen multiple interactions ISO RGD:1318735 6480464 ebselen inhibits the reaction [Zinc binds to XPA protein] CTD PMID:15265038 epoxiconazole increases expression ISO RGD:1318736 6480464 epoxiconazole results in increased expression of XPA mRNA CTD PMID:35436446 folic acid multiple interactions ISO RGD:1318735 6480464 Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of XPA mRNA] CTD PMID:30020114 furan decreases expression EXP 6480464 furan results in decreased expression of XPA mRNA CTD PMID:22507866 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of XPA mRNA CTD PMID:22061828 gold atom multiple interactions ISO RGD:1318735 6480464 [Polyethyleneimine binds to Gold] which results in increased expression of XPA mRNA CTD PMID:28433809 gold(0) multiple interactions ISO RGD:1318735 6480464 [Polyethyleneimine binds to Gold] which results in increased expression of XPA mRNA CTD PMID:28433809 hydrogen peroxide multiple interactions ISO RGD:1318735 6480464 [Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of XPA mRNA CTD PMID:21751221 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of XPA mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:1318735 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of XPA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of XPA mRNA CTD PMID:28628672 irinotecan decreases expression ISO RGD:1318735 6480464 Irinotecan results in decreased expression of XPA protein CTD PMID:11593056 isoprenaline increases expression ISO RGD:1318736 6480464 Isoproterenol results in increased expression of XPA mRNA CTD PMID:20003209 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of XPA mRNA CTD PMID:19700661 lead diacetate increases expression ISO RGD:1318736 6480464 lead acetate results in increased expression of XPA mRNA CTD PMID:22609695 lipopolysaccharide increases expression ISO RGD:1318736 6480464 Lipopolysaccharides results in increased expression of XPA mRNA CTD PMID:19339665 lipopolysaccharide multiple interactions ISO RGD:1318736 6480464 methyldithiocarbamate promotes the reaction [Lipopolysaccharides results in increased expression of XPA mRNA] CTD PMID:19339665 lovastatin increases expression EXP 6480464 Lovastatin results in increased expression of XPA mRNA CTD PMID:26739623 metam multiple interactions ISO RGD:1318736 6480464 methyldithiocarbamate promotes the reaction [Lipopolysaccharides results in increased expression of XPA mRNA] CTD PMID:19339665 methyl methanesulfonate increases expression ISO RGD:1318735 6480464 Methyl Methanesulfonate results in increased expression of XPA mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1318735 6480464 methylmercuric chloride results in decreased expression of XPA mRNA CTD PMID:28001369 mitomycin C decreases response to substance ISO RGD:1318736 6480464 XPA protein results in decreased susceptibility to Mitomycin CTD PMID:23153559 paracetamol multiple interactions ISO RGD:1318736 6480464 O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1, 2-diolate inhibits the reaction [Acetaminophen results in increased expression of XPA mRNA] CTD PMID:12540782 paracetamol increases expression ISO RGD:1318736 6480464 Acetaminophen results in increased expression of XPA mRNA CTD PMID:12540782 paracetamol affects expression ISO RGD:1318736 6480464 Acetaminophen affects the expression of XPA mRNA CTD PMID:17562736 paraquat increases expression ISO RGD:1318736 6480464 Paraquat results in increased expression of XPA mRNA CTD PMID:21463325 phenacetin increases response to substance ISO RGD:1318736 6480464 XPA gene mutant form results in increased susceptibility to Phenacetin CTD PMID:16464479 PhIP affects response to substance ISO RGD:1318736 6480464 XPA protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine CTD PMID:10755388 more ... PhIP multiple interactions ISO RGD:1318736 6480464 XPA protein affects the reaction [2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:10755388 pirinixic acid affects response to substance ISO RGD:1318736 6480464 XPA protein affects the susceptibility to pirinixic acid CTD PMID:23153559 rac-lactic acid decreases expression ISO RGD:1318735 6480464 Lactic Acid results in decreased expression of XPA mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:1318735 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of XPA mRNA CTD PMID:23557933 Se-methyl-L-selenocysteine multiple interactions ISO RGD:1318735 6480464 selenomethylselenocysteine inhibits the reaction [Zinc binds to XPA protein] CTD PMID:15265038 Se-methylselenocysteine multiple interactions ISO RGD:1318735 6480464 selenomethylselenocysteine inhibits the reaction [Zinc binds to XPA protein] CTD PMID:15265038 selenocystine multiple interactions ISO RGD:1318735 6480464 selenocystine inhibits the reaction [Zinc binds to XPA protein] CTD PMID:15265038 selenocystine decreases activity ISO RGD:1318736 6480464 selenocystine results in decreased activity of XPA protein CTD PMID:15265038 selenomethionine multiple interactions ISO RGD:1318735 6480464 Selenomethionine inhibits the reaction [Zinc binds to XPA protein] CTD PMID:15265038 senecionine increases expression ISO RGD:1318736 6480464 senecionine results in increased expression of XPA protein CTD PMID:35357534 silver atom decreases expression ISO RGD:1318736 6480464 Silver results in decreased expression of XPA mRNA CTD PMID:22576574 silver(0) decreases expression ISO RGD:1318736 6480464 Silver results in decreased expression of XPA mRNA CTD PMID:22576574 sodium arsenite decreases expression ISO RGD:1318736 6480464 sodium arsenite results in decreased expression of XPA protein CTD PMID:28237621 sodium arsenite affects expression ISO RGD:1318735 6480464 sodium arsenite affects the expression of XPA mRNA CTD PMID:29319823 sodium arsenite decreases expression ISO RGD:1318735 6480464 sodium arsenite results in decreased expression of XPA mRNA, sodium arsenite results in decreased expression of XPA protein CTD PMID:28237621 sodium arsenite multiple interactions ISO RGD:1318735 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPA mRNA more ... CTD PMID:28552776 , PMID:32031413 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of XPA mRNA CTD PMID:12841865 testosterone decreases expression ISO RGD:1318735 6480464 Testosterone results in decreased expression of XPA mRNA CTD PMID:33359661 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of XPA mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of XPA mRNA CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of XPA mRNA CTD PMID:34492290 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in decreased expression of XPA mRNA CTD PMID:31129395 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of XPA mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO RGD:1318735 6480464 trichostatin A inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPA mRNA], trichostatin A inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPA protein] CTD PMID:32031413 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of XPA mRNA CTD PMID:30589522 valproic acid decreases methylation ISO RGD:1318735 6480464 Valproic Acid results in decreased methylation of XPA gene CTD PMID:29154799 vorinostat decreases expression ISO RGD:1318736 6480464 Vorinostat results in decreased expression of XPA mRNA CTD PMID:32512035 Y-27632 increases expression ISO RGD:1318735 6480464 Y 27632 results in increased expression of XPA mRNA CTD PMID:20878077 zidovudine increases expression ISO RGD:1318735 6480464 Zidovudine results in increased expression of XPA mRNA, Zidovudine results in increased expression of XPA protein CTD PMID:21192964 , PMID:23675285 zinc atom multiple interactions ISO RGD:1318735 6480464 2-nitrophenyl selenocyanic acid inhibits the reaction [Zinc binds to XPA protein] more ... CTD PMID:15265038 more ... zinc atom affects binding ISO RGD:1318735 6480464 Zinc binds to XPA protein CTD PMID:10783332 more ... zinc(0) multiple interactions ISO RGD:1318735 6480464 2-nitrophenyl selenocyanic acid inhibits the reaction [Zinc binds to XPA protein] more ... CTD PMID:15265038 more ... zinc(0) affects binding ISO RGD:1318735 6480464 Zinc binds to XPA protein CTD PMID:10783332 more ...